CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Selexipag

司来帕格 杂质对照品Selexipag Impurities

32 个杂质条目32 impurity entries

本页汇总 司来帕格 的 32 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 32 impurity reference standards of Selexipag. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 司来帕格(Selexipag)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment of an efficient stability-indicating LC-MS/MS method for the analysis of selexipag and characterization of its degradation products
    Biomedical chromatography : BMC · 2021 · Amara Babu NLA et al.  ·  PMID 33998014  ·  DOI
  2. 分析方法Analytical MethodsSimultaneous quantification and pharmacokinetic investigation of selexipag and its main metabolite ACT-333679 in rat plasma by UPLC-MS/MS method
    Journal of pharmaceutical and biomedical analysis · 2020 · Xie S et al.  ·  PMID 32768890  ·  DOI

司来帕格 —— 原料药与杂质对照品Selexipag — drug substance & impurities

共 33 个条目(含原料药本体)33 items incl. the drug substance
Selexipag structure
原料药 APIAPI
司来帕格Selexipag
Selexipag
CAS No.475086-01-2
Chemical FormulaC26H32N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 4 structure
4
司来帕格杂质4Selexipag Impurity 4
Selexipag Impurity 4
CAS No.475085-57-5
Chemical FormulaC25H29N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 5 structure
5
司来帕格杂质5Selexipag Impurity 5
Selexipag Impurity 5
CAS No.2732400-56-3
Chemical FormulaC25H29N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 7 structure
7
司来帕格杂质7Selexipag Impurity 7
Selexipag Impurity 7
CAS No.2287345-22-4
Chemical FormulaC27H33N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 8 structure
8
司来帕格杂质8Selexipag Impurity 8
Selexipag Impurity 8
CAS No.475084-96-9
Chemical FormulaC29H37N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 9 structure
9
司来帕格杂质9Selexipag Impurity 9
Selexipag Impurity 9
CAS No.57038-62-7
Chemical FormulaC16H10Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 10 structure
10
司来帕格杂质10Selexipag Impurity 10
Selexipag Impurity 10
CAS No.42042-66-0
Chemical FormulaC7H15NO2
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 11 structure
11
司来帕格杂质11Selexipag Impurity 11
Selexipag Impurity 11
CAS No.35688-18-7
Chemical FormulaC3H7NO4S
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 20 structure
20
司来帕格杂质20Selexipag Impurity 20
Selexipag Impurity 20
CAS No.2514706-51-3
Chemical FormulaC20H21N3O
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 21 structure
21
司来帕格杂质21Selexipag Impurity 21
Selexipag Impurity 21
CAS No.2928611-79-2
Chemical FormulaC22H23N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 22 structure
22
司来帕格杂质22Selexipag Impurity 22
Selexipag Impurity 22
CAS No.2928611-22-5
Chemical FormulaC23H26N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 30 structure
30
司来帕格杂质30Selexipag Impurity 30
Selexipag Impurity 30
CAS No.18591-57-6
Chemical FormulaC16H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 31 structure
31
司来帕格杂质31Selexipag Impurity 31
Selexipag Impurity 31
CAS No.41270-66-0
Chemical FormulaC16H11ClN2
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 32 structure
32
司来帕格杂质32Selexipag Impurity 32
Selexipag Impurity 32
CAS No.475086-75-0
Chemical FormulaC23H27N3O
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 36 structure
36
司来帕格杂质36Selexipag Impurity 36
Selexipag Impurity 36
CAS No.475086-28-3
Chemical FormulaC25H30N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 39 structure
39
司来帕格杂质39Selexipag Impurity 39
Selexipag Impurity 39
CAS No.2068134-98-3
Chemical FormulaC19H19N3
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 45 structure
45
司来帕格杂质45Selexipag Impurity 45
Selexipag Impurity 45
CAS No.42042-71-7
Chemical FormulaC7H17NO
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 4-d6 structure
4-D6
司来帕格杂质4-d6Selexipag Impurity 4-d6
Selexipag Impurity 4-d6
CAS No.1265295-56-4
Chemical FormulaC25H23D6N3O3
Purity>95%询价On request
Selexipag Impurity 4-d7 structure
4-D7
司来帕格杂质4-d7Selexipag Impurity 4-d7
Selexipag Impurity 4-d7
CAS No.1265295-20-2
Chemical FormulaC25H22D7N3O3
Purity>95%询价On request
Selexipag Impurity 49 structure
49
司来帕格杂质49Selexipag Impurity 49
Selexipag Impurity 49
CAS No.2010956-45-1
Chemical FormulaC10H22N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 51 structure
51
司来帕格杂质51Selexipag Impurity 51
Selexipag Impurity 51
CAS No.3144-09-0
Chemical FormulaCH5NO2S
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 56 structure
56
司来帕格杂质56Selexipag Impurity 56
Selexipag Impurity 56
CAS No.475086-99-8
Chemical FormulaC24H27N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 58 structure
58
司来帕格杂质58Selexipag Impurity 58
Selexipag Impurity 58
CAS No.1157086-87-7
Chemical FormulaC8H19NO
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 63 structure
63
司来帕格杂质63Selexipag Impurity 63
Selexipag Impurity 63
CAS No.475086-95-4
Chemical FormulaC20H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 65 structure
65
司来帕格杂质65Selexipag Impurity 65
Selexipag Impurity 65
CAS No.2375113-56-5
Chemical FormulaC26H32N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 69 structure
69
司来帕格杂质69Selexipag Impurity 69
Selexipag Impurity 69
CAS No.39099-24-6
Chemical FormulaC7H17N
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 70 structure
70
司来帕格杂质70Selexipag Impurity 70
Selexipag Impurity 70
CAS No.39099-23-5
Chemical FormulaC7H17N
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 71 structure
71
司来帕格杂质71Selexipag Impurity 71
Selexipag Impurity 71
CAS No.99911-48-5
Chemical FormulaC4H7NO5S·C6H15N
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 72 structure
72
司来帕格杂质72Selexipag Impurity 72
Selexipag Impurity 72
CAS No.243472-70-0
Chemical FormulaC16H11BrN2
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 73 structure
73
司来帕格杂质73Selexipag Impurity 73
Selexipag Impurity 73
CAS No.1588-89-2
Chemical FormulaC16H12N2
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 74 structure
74
司来帕格杂质74Selexipag Impurity 74
Selexipag Impurity 74
CAS No.1056-77-5
Chemical FormulaC28H20O
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 87 structure
87
司来帕格杂质87Selexipag Impurity 87
Selexipag Impurity 87
CAS No.50595-15-8
Chemical FormulaC6H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Selexipag Impurity 88 structure
88
司来帕格杂质88Selexipag Impurity 88
Selexipag Impurity 88
CAS No.50595-15-9
Chemical FormulaC29H37N3O6
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

司来帕格 —— 研究文献与合成路线Selexipag — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 司来帕格 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Selexipag. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Development of an efficient stability-indicating LC-MS/MS method for the analysis of selexipag and characterization of its degradation products
    Amara Babu NLA, Koganti K, Palakeeti B, et al. · Biomedical chromatography : BMC · 2021 · 被引 1cited 1

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

司来帕格 杂质谱研究要点Selexipag — impurity profiling notes

下面这些是拿到 司来帕格 的 33 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 33 impurity entries for Selexipag, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances